Press "Enter" to skip to content

FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder

FDA approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disorder. This is the first FDA approval of a treatment for LEMS.

Original source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm627093.htm

Also Read:   Public Safety Alert Due to Marketing of Unapproved Stem Cell and Exosome Products